Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Wang

Showing results (61-70 of 167) with videos related to

Pageof 17
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 25, 2019
Bone-Forming and Antiresorptive Effects of Romosozumab in Postmenopausal Women With Osteoporosis: Bone Histomorphometry and Microcomputed Tomography Analysis After 2 and 12 Months of TreatmentPascale Chavassieux, Roland Chapurlat, Nathalie Portero-Muzy, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2019
NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivorsAndrea Wang-Gillam, Richard A Hubner, Jens T Siveke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2016
Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance in Pancreatic Ductal AdenocarcinomaDaoxiang Zhang, Lin Li, Hongmei Jiang, et al.
Lancet (London, England)|January 10, 2006
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trialStephen Tyring, Alice Gottlieb, Kim Papp, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 22, 2007
Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMDE Michael Lewiecki, Paul D Miller, Michael R McClung, et al.
The Journal of Sexual Medicine|August 13, 2011
Women's bike seats: a pressing matter for competitive female cyclistsMarsha K Guess, Sarah N Partin, Steven Schrader, et al.
The Lancet. Diabetes & Endocrinology|April 11, 2018
Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority studyKenneth G Saag, Rachel B Wagman, Piet Geusens, et al.
Systematic Reviews|July 13, 2023
Impact of iron supplementation on patient outcomes for women with abnormal uterine bleeding: a protocol for a systematic review and meta-analysisHasmik Nazaryan, Megan Watson, Dana Ellingham, et al.
Headache|August 7, 2021
Timing and durability of response to erenumab in patients with chronic migraineStewart J Tepper, Sylvia Lucas, Messoud Ashina, et al.
The Journal of Clinical Investigation|June 24, 2020
TPL2 enforces RAS-induced inflammatory signaling and is activated by point mutationsPaarth B Dodhiawala, Namrata Khurana, Daoxiang Zhang, et al.
Pageof 17

Showing results (61-70 of 167) with videos related to

Sort By:
Pageof 17
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 25, 2019
Bone-Forming and Antiresorptive Effects of Romosozumab in Postmenopausal Women With Osteoporosis: Bone Histomorphometry and Microcomputed Tomography Analysis After 2 and 12 Months of TreatmentPascale Chavassieux, Roland Chapurlat, Nathalie Portero-Muzy, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2019
NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivorsAndrea Wang-Gillam, Richard A Hubner, Jens T Siveke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2016
Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance in Pancreatic Ductal AdenocarcinomaDaoxiang Zhang, Lin Li, Hongmei Jiang, et al.
Lancet (London, England)|January 10, 2006
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trialStephen Tyring, Alice Gottlieb, Kim Papp, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 22, 2007
Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMDE Michael Lewiecki, Paul D Miller, Michael R McClung, et al.
The Journal of Sexual Medicine|August 13, 2011
Women's bike seats: a pressing matter for competitive female cyclistsMarsha K Guess, Sarah N Partin, Steven Schrader, et al.
The Lancet. Diabetes & Endocrinology|April 11, 2018
Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority studyKenneth G Saag, Rachel B Wagman, Piet Geusens, et al.
Systematic Reviews|July 13, 2023
Impact of iron supplementation on patient outcomes for women with abnormal uterine bleeding: a protocol for a systematic review and meta-analysisHasmik Nazaryan, Megan Watson, Dana Ellingham, et al.
Headache|August 7, 2021
Timing and durability of response to erenumab in patients with chronic migraineStewart J Tepper, Sylvia Lucas, Messoud Ashina, et al.
The Journal of Clinical Investigation|June 24, 2020
TPL2 enforces RAS-induced inflammatory signaling and is activated by point mutationsPaarth B Dodhiawala, Namrata Khurana, Daoxiang Zhang, et al.
Pageof 17